dupixent and tirzepatide DUPIXENT® (dupilumab) Mechanism of Action for Uncontrolled Moderate-to-Severe Atopic Dermatitis DUPIXENT® (dupilumab) Dosage & Administration

The REWIND trial (N=9,901) demonstrated that dulaglutide 1.5 mg reduced major adverse cardiovascular events (MACE) by 12% compared to placebo over a median 5.4-year follow-up (HR 0.88, 95% CI 0.79-0.99) [2]

Broken Seal or Damaged Vial: If the bottle or pen looks damaged or the safety seal is broken, dont use it

The differential insulinotropic potency and other physiological effects of GIP and GLP-1 in both healthy individuals and those with T2DM may be linked to their distinct receptors and the downstream G proteins that transmit signals intracellularly

3Bn is about right for 1.2 million patients and 2000 pounds a year

Ozempic alternatives Ozempic is just one of several GLP-1 (or GIP/GLP-1) diabetes medications your healthcare provider might consider prescribing

Tirzepatide can help reduce overall body fat, including abdominal fat